Bredin Investment’s Novartis NVS Stock Holding History

Bredin Investment’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$500K	Hold	5,279	–	–	0.41%	58
2019 Q3	$459K	Hold	5,279	–	–	0.4%	59
2019 Q2	$466K	Sell	5,279 -612	-10%	-$51.8K	0.41%	58
2019 Q1	$508K	Hold	5,891	–	–	0.44%	51
2018 Q4	$453K	Hold	5,891	–	–	0.43%	54
2018 Q3	$455K	Hold	5,891	–	–	0.37%	56
2018 Q2	$399K	Hold	5,891	–	–	0.31%	59
2018 Q1	$427K	Hold	5,891	–	–	0.37%	51
2017 Q4	$447K	Buy	+5,891	New	+$444K	0.36%	52

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Bredin Investment's NVS Position: Q4 2019 in Review

Bredin Investment held its Novartis (NVS) position steady in Q4 2019 at 5,279 shares worth $500K. The position accounts for 0.41% of the portfolio, ranked #58.

Bredin Investment first reported a position in NVS in Q4 2017 and has held it in 9 quarters since. The position peaked at $508K in Q1 2019. 1,173 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

Bredin Investment held 5,279 shares of Novartis worth $500K as of Q4 2019.
Bredin Investment left its Novartis share count unchanged in Q4 2019.
Novartis made up 0.41% of Bredin Investment's portfolio in Q4 2019, its #58 holding.
Bredin Investment first reported a position in Novartis in Q4 2017 and has held it in 9 quarters since.
Bredin Investment's Novartis position peaked at $508K in Q1 2019.
1,173 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Bredin Investment's 13F filing for Q4 2019, filed 6 Feb 2020.